Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000–2007

References

• Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263–9.
   PubMed Web of Science ®Google Scholar
• Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Hakala M, Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52:36–41.
   PubMed Web of Science ®Google Scholar
• Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Jarvenpaa S, Leirisalo-Repo M, The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Arthritis Rheum 2009;60:1222–31.
   PubMed Web of Science ®Google Scholar
• [Rheumatoid arthritis (online). Current care guideline], in Finnish. Working Group set up by the Finnish Medical Society Duodecim and the Finnish Society for Rheumatology. Helsinki: The Finnish Medical Society Duodecim, 2003. Available from: http://www.kaypahoito.fi (accessed 13 August 2009).
   Google Scholar
• Bijlsma JW, Jacobs JW. [The practice guideline ‘Rheumatoid arthritis’ (first revision) from the Dutch College of General Practitioners: a response from the perspective of rheumatology], in Dutch. Ned Tijdschr Geneeskd 2004;148:557–8.
   PubMedGoogle Scholar
• Le Loet X, Berthelot JM, Cantagrel A, Combe B, De Bandt M, Fautrel B, Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis 2006;65:45–50.
   PubMedGoogle Scholar
• Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762–84.
   PubMed Web of Science ®Google Scholar
• Deighton C, O'Mahony R, Tosh J, Turner C, Rudolf M. Management of rheumatoid arthritis: summary of NICE guidance. Br Med J 2009;338:b702.
   PubMed Web of Science ®Google Scholar
• Mottonen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568–73.
   PubMed Web of Science ®Google Scholar
• ATC/DDD Index 2010. WHO Collaborating Centre for Drug Statistics Methodology. Available from. http://www.whocc.no/atcddd/.
   Google Scholar
• Sokka T, Envalds M, Pincus T. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol 2008;18:228–39.
   PubMed Web of Science ®Google Scholar
• Kvalvik AG, Aadland HA, Hoyeraal HM, Larsen S. Were the patterns of treatment for rheumatoid arthritis during 1977–1992 consistent with modern clinical guidelines?. Scand J Rheumatol 2001;30:61–8.
   PubMedGoogle Scholar
• Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum 2007;57:928–34.
   PubMed Web of Science ®Google Scholar
• van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Dijkmans BA, Boers M. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?. Ann Rheum Dis 2007;66:974–6.
   PubMed Web of Science ®Google Scholar
• Kiely P, Williams R, Walsh D, Young A. Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort. Rheumatology (Oxford) 2009;48:57–60.
   PubMed Web of Science ®Google Scholar
• Jobanputra P, Wilson J, Douglas K, Burls A. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology (Oxford) 2004;43:206–10.
   PubMed Web of Science ®Google Scholar
• Maetzel A, Bombardier C, Strand V, Tugwell P, Wells G. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey. J Rheumatol 1998;25:2331–8.
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Rabidou N, Dhar R. Are rheumatologists' treatment decisions influenced by patients' age?. Rheumatology (Oxford) 2006;45:1555–7.
   PubMed Web of Science ®Google Scholar
• Maravic M, Berge C, Daures JP, Boissier MC. Survey of practices regarding management of early rheumatoid arthritis by rheumatologists in France. Clin Exp Rheumatol 2004;22:319–27.
   PubMedGoogle Scholar
• Carli C, Ehlin AG, Klareskog L, Lindblad S, Montgomery SM. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics. Ann Rheum Dis 2006;65:1102–5.
   PubMed Web of Science ®Google Scholar
• Saraux A, Berthelot JM, Chales G, Le Henaff C, Thorel J, Hoang S, Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France). Joint Bone Spine 2002;69:37–42.
   PubMedGoogle Scholar
• Sokka T, Pincus T. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. J Rheumatol 2002;29:2521–4.
   PubMed Web of Science ®Google Scholar
• Ward MM. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980–1995: results from the National Ambulatory Medical Care Surveys. J Rheumatol 1999;26:546–50.
   PubMedGoogle Scholar
• Aletaha D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford) 2002;41:1367–74.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Inoue E, Singh G, Tanaka E, Nakajima A, Taniguchi A, Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol 2007;17:283–9.
   PubMedGoogle Scholar
• Berard A, Solomon DH, Avorn J. Patterns of drug use in rheumatoid arthritis. J Rheumatol 2000;27:1648–55.
   PubMed Web of Science ®Google Scholar
• Edwards CJ, Arden NK, Fisher D, Saperia JC, Reading I, Van Staa TP, The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford) 2005;44:1394–8.
   PubMedGoogle Scholar
• Albers JM, Paimela L, Kurki P, Eberhardt KB, Emery P, van ‘t Hof MA, Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:453–8.
   PubMed Web of Science ®Google Scholar
• Sokka T, Kautiainen H, Toloza S, Mäkinen H, Verstappen SM, Lund Hetland M, QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007;66:1491–6.
   PubMed Web of Science ®Google Scholar
• Luukkainen R, Kajander A, Isomäki H. Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol 1977;6:189–92.
   PubMed Web of Science ®Google Scholar
• Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894–8.
   PubMed Web of Science ®Google Scholar
• Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004;50:2072–81.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006;55:864–72.
   PubMed Web of Science ®Google Scholar
• van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM, Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007;56:1424–32.
   PubMed Web of Science ®Google Scholar
• Finckh A. Early inflammatory arthritis versus rheumatoid arthritis. Curr Opin Rheumatol 2009;21:118–23.
   PubMedGoogle Scholar